https://orcid.org/0000-0003-3938-3347
References
- Callaway E. Heavily mutated omicron variant puts scientists on alert. Nature. 2021;2021:108.
- World Health Organization. Classification of Omicron; 2021. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accessed January 22, 2022.
- Saxena SK, Kumar S, Ansari S, et al. Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective. J Med Virol. 2022;2022:1‐7.
- World Health Organization. Enhancing response to Omicron SARS-CoV-2 variant; 2021. Available from: https://www.who.int/docs/default-source/coronaviruse/2021-12-23-global-technical-brief-and-priority-action-on-omicron.pdf?sfvrsn=d0e9fb6c_8. Accessed January 22, 2022.
- World Health Organization. Enhancing response to Omicron SARS-CoV-2 variant; 2022. Available from: https://www.who.int/docs/default-source/coronaviruse/2022-01-07-global-technical-brief-and-priority-action-on-omicron---corr2.pdf?sfvrsn=918b09d_26. Accessed January 22, 2022.
- He X, Hong W, Pan X, Lu G, Wei X. Severe acute respiratory syndrome coronavirus 2 Omicron variant: characteristics and prevention. MedComm. 2021;2:838–845. doi:10.1002/mco2.110
- Oliaei S, SeyedAlinaghi S, Mehrtak M, et al. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review. Eur J Med Res. 2021;26(1):96. doi:10.1186/s40001-021-00570-2
- Government of India, Ministry of health and family welfare. Vaccination state wise; 2022. Available from: https://www.mohfw.gov.in/. Accessed January 22, 2022.
- Murhekar MV, Bhatnagar T, Thangaraj JWV, et al. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: a population-based cross-sectional study. PLoS Med. 2021;18(12):e1003877. doi:10.1371/journal.pmed.1003877
- Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043–2054. doi:10.1001/jama.2021.19499
- Espenhain L, Funk T, Overvad M, et al. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021. Euro Surveill. 2021;26(50):2101146. doi:10.2807/1560-7917.ES.2021.26.50.2101146
- Ikemura N, Hoshino A, Higuchi Y, Taminishi S, Inaba T, Matoba S. SARS-CoV-2 Omicron variant escapes neutralization by vaccinated and convalescent sera and therapeutic monoclonal antibodies. medRxiv. 2021. doi:10.1101/2021.12.13.21267761
- SeyedAlinaghi SA, Karimi A, MohsseniPour M, et al. The clinical outcomes of COVID‐19 in HIV‐positive patients: a systematic review of current evidence. ImmunInflamm Dis. 2021;9:1160‐1185.
- SeyedAlinaghi SA, Karimi A, Shobeiri P, et al. Psychological symptoms of COVID–19 epidemic: a systematic review of current evidence. Psihologija. 2021;54(2):173–192. doi:10.2298/PSI200703035S
- Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437–446. doi:10.1016/S0140-6736(22)00017-4
- Government of India, Ministry of Health and Family Welfare. District-wise COVID-19 test positivity rates. 14th January to 20th January, 2022. Available from: https://www.mohfw.gov.in/. Accessed January 22, 2022.
- Nealon J, Cowling BJ. Omicron severity: milder but not mild. Lancet. 2022;399:412–413. doi:10.1016/S0140-6736(22)00056-3
- McMahan K, Giffin V, Tostanoski LH, et al. Reduced pathogenicity of the SARS-CoV-2 omicron variant in Hamsters. bioRxiv. 2022. doi:10.1016/j.medj.2022.03.004
- Del Rio C, Omer SB, Malani PN. Winter of omicron—the evolving COVID-19 pandemic. JAMA. 2022;327(4):319–320. doi:10.1001/jama.2021.24315
- Jansen L, Tegomoh B, Lange K, et al. Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant cluster – Nebraska, November–December 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1782–1784. doi:10.15585/mmwr.mm705152e3
- Peiris JS, Chu CM, Cheng V, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. doi:10.1016/S0140-6736(03)13412-5
- He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of covid-19. Nat Med. 2020;26:672–675. doi:10.1038/s41591-020-0869-5
- National Institute of Infectious Diseases in Japan: (Pango lineage B.1.1.529) preliminary report on infectious period; 2022. Available from: www.niid.go.jp/niid/en/2019-ncov-e/10884-covid19-66-en.html. Accessed January 22, 2022.